Delivery Order SPE2DB24D2012-SPE2DB24FBVUV
Award Date
9/24/24
Potential Completion Date
9/25/24
Potential Value
$7.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,625.30 and is a firm fixed-price delivery order with a completion date of November 5, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies....
The federal contract award is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,575.18, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 4, 2024. The contract has a completion date of November 5, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,111.33 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 15, 2024, with an ultimate completion date of August 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, for the supply of a...
This federal contract award is for the pharmaceutical product XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, with a ceiling value of $1,615.61. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of June 17, 2025. It is not designated as a set-aside contract, indicating...
This federal contract award is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products to the U.S. Department of Defense's Medical Supply Chain agency. The $1,607.18 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 23, 2024, with a completion date of July 24, 2024. This order is a part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, with a ceiling value of $1,273.95 and a completion date of February 12, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, with a ceiling value of $2,716.10 and a completion date of December 31, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
The federal contract award is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $1,369.35, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a term running through January 23, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,511.04 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 28, 2024 with a completion date of October 29, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $2,546.28, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of November 7, 2022 and is a Delivery Order issued under a Firm Fixed Price contract type. The prime contractor, Amerisourcebergen Drug Corp, is a major...